Post-market Surveillance of Micorport CRM Cardiac Implantable Electronic Devices

This is a post-market surveillance study following patients who have received a MicroPort cardiac implantable electronic device — such as a pacemaker or defibrillator — to monitor how these devices perform in real-world conditions over time. **You may be eligible if...** - You have received one of several specific MicroPort pacemakers, ICDs (implantable defibrillators), or CRT-D devices after January 2020 - Your device was implanted along with approved MicroPort leads (wires connecting the device to the heart) - You are able and willing to attend follow-up visits **You may NOT be eligible if...** - You have a life expectancy of less than 12 months - You are unable to attend the required follow-up visits - You are pregnant - You are already enrolled in another study that conflicts with this one Talk to your doctor to see if this trial is right for you.